The origin of ECI
The European cannabis sector is maturing quickly, but many organisations still face the same core challenge: turning ambition into reliable GMP practice. ECI is designed to support that transition through education, certification, assessment tools, templates, intelligence and corporate capability-building.
The aim is not to make cannabis look pharmaceutical for marketing purposes. The aim is to help companies, professionals and healthcare stakeholders understand what credible, risk-based, patient-focused quality looks like in practice.
Founder-led pharmaceutical experience
ECI is founder-led by Gary McPolin, a senior CQV and pharmaceutical manufacturing professional with experience across sterile manufacturing, biotech, cleanrooms, validation, qualification, environmental monitoring, GMP readiness and project delivery in regulated European environments.
That background shapes the institute. ECI is not being built as a generic cannabis education brand. It is being built around the disciplines that matter when cannabis products, facilities and organisations need to become more professional: quality systems, validation, documentation, training, regulatory readiness, contamination control and operational maturity.
The institute model
ECI is structured around a simple maturity journey:
Learn
Build practical knowledge through individual courses and pathways.
Certify
Demonstrate competence through professional certifications.
Assess
Benchmark readiness using structured tools and maturity models.
Improve
Use templates, training and corporate support to close gaps.
Lead
Contribute to a more capable European cannabis sector.
Scientific leadership and advisory model
ECI is being developed with an institute-style governance model. The future structure includes scientific direction, subject-matter contributors and an advisory network covering GMP, healthcare, cultivation, extraction, regulatory affairs, quality systems and industry intelligence.
Scientific Director: Adriana is intended to support the scientific and academic direction of ECI as the platform develops. The advisory board section will be expanded as formal roles, collaborators and institutional relationships are confirmed.
Core principles
Pharmaceutical discipline
Use proven GMP, validation and quality principles without pretending cannabis is identical to traditional pharma.
Practical education
Teach what professionals can apply in real facilities, not abstract theory alone.
European relevance
Focus on European regulatory, operational and market realities.
Trust and transparency
Build credibility through evidence, clear methodology and responsible positioning.